Autologous peptides constitutively occupy the antigen binding site on Ia.
about
Contribution of mass spectrometry to contemporary immunology.Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization.Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule.The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides "in vivo".Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopyRelative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses.Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange.Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.Binding interactions between peptides and proteins of the class II major histocompatibility complex.Kinetics of chlamydial antigen processing and presentation to T cells by paraformaldehyde-fixed murine bone marrow-derived macrophagesKinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class IIImmunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.The relationship between antigen concentration, antigen internalization, and antigenic complexes: modeling insights into antigen processing and presentationExpression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH.Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.A gene required for class II-restricted antigen presentation maps to the major histocompatibility complexSpecialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta.MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentationAnalysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptidesCytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA moleculeA peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock familyDeterminant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune diseaseEnhancement of peptide antigen presentation by a second peptide.Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virusIdentification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-AkA first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules.Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.Finding the groove.Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.Measurement of MHC/peptide interactions by gel filtration.Distinct antigen MHC class II complexes generated by separate processing pathways.Selective interaction of Ni with an MHC-bound peptide.Juvenile chronic arthritis--a time for change?Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes.Recognition by class II alloreactive T cells of processed determinants from human serum proteins.Comparison of TCR-alpha beta sequences of cross-reactive anti-DR alloreactive T-cell clones: identification of possible contact residues based on charge complementarity between TCR chains and DR determinants.Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unit.
P2860
Q30697033-E6AFC3CD-C663-42EE-A509-3AE5C8C623AAQ33206148-7E8B3B20-25B7-41DE-B309-293D246CEA36Q33541540-B377217F-7852-4B01-8973-792638DAEF40Q33676045-7713EE88-E3AE-4D18-AC52-2D1D2B125531Q33796819-18EADC47-D2BF-41B8-97A0-FA36099E1EB0Q33847346-B05AD177-03BF-4982-B13A-B19A93C08428Q33863544-08172AD6-6B4D-422D-90E3-517C443C5232Q33867750-4C82DF30-5BE7-4B9D-8E67-60A7DE2CF6FBQ33920167-AA4695B1-4301-4732-9E9E-AC4768514625Q34540061-73D7E524-9C3C-439E-B14F-77932AC61803Q35393105-A43C1A36-6DCD-4A99-9B76-9429D11814B8Q35750583-E746E5DA-3FD6-4C16-92D9-3A5FFBA52247Q35890031-E250CC36-389B-4E28-AB92-0DD3EB4147D0Q36223215-898B5B6E-25C1-4C55-BBFB-85D565B4108BQ36230148-8A2053BE-AAF0-43EE-8633-ED4D103D43CAQ36230523-10E6A130-DBA3-485C-A547-C42BD0283B90Q36230650-7BF2E575-0151-4F0C-9C2F-7C84B4B90771Q36350723-E2C6EBCA-59A6-4E02-BC3D-E79F0D110CADQ36351143-E26B0434-522E-483A-9854-76FE22CA6472Q36353387-7FA9B11F-36C6-4ED3-9D96-BB1098052303Q36353393-59C9467B-F182-4EB8-9ED5-188DB74D0027Q36357055-200B6F2B-B8CF-4406-8EA2-963906665AB9Q36362580-6673CEAE-32D4-4C0C-A51A-66F4AFACD02AQ36554333-6D98220E-703B-4579-A898-C6CF4C529B69Q36629062-94419263-3F95-49C6-A402-6FFFDC3A5081Q37147375-60B107E8-533F-4DBD-8844-FB42DF493D75Q37594729-7104AB50-846C-408E-8CD5-E3BC2D839090Q37803532-664D5693-BE30-4447-BB2F-8A6AED10E113Q38574232-C00104FB-C3E4-42E3-84E2-54A2800E8D76Q39849181-55801403-F8AB-48BC-A474-0B1143EE508BQ39989093-E7CC6B2B-A185-4BE2-9470-3328713D2AB0Q41079003-03FEF42E-2B0C-41BF-A96A-07DA841D2E5AQ41080835-38028579-E3B4-4830-8B0A-672F714FB2DFQ41108664-928677C7-ADEA-4149-9FB2-923FC8E658EAQ41515448-AA6FF548-1A97-42CD-986B-71A0CFEF7733Q41679755-FBB33B0C-E458-40B7-A7E6-CD6CD4D93F54Q42608594-FF816AE2-943D-4470-A2D4-755E94067433Q42941471-44519457-2699-4EDB-A0E1-776932BF0825Q43118417-0F6CAFCF-CA56-4612-9843-88C502C9B49EQ55003903-E5F63F45-38A2-41F0-85D1-F1F784287F64
P2860
Autologous peptides constitutively occupy the antigen binding site on Ia.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Autologous peptides constitutively occupy the antigen binding site on Ia.
@en
Autologous peptides constitutively occupy the antigen binding site on Ia.
@nl
type
label
Autologous peptides constitutively occupy the antigen binding site on Ia.
@en
Autologous peptides constitutively occupy the antigen binding site on Ia.
@nl
prefLabel
Autologous peptides constitutively occupy the antigen binding site on Ia.
@en
Autologous peptides constitutively occupy the antigen binding site on Ia.
@nl
P2093
P356
P1433
P1476
Autologous peptides constitutively occupy the antigen binding site on Ia.
@en
P2093
P304
P356
10.1126/SCIENCE.3194755
P407
P577
1988-11-01T00:00:00Z